According to The Freeport News, Bahama-based PharmaChem Technologies and Gilead Sciences broke ground on a two-and-a-half year multi-million dollar expansion project. The expansion to the facility is expected to cost about $130 million and once complete will see PharmaChem increase its head count from about 130 staff members to 220. The new state-of-the-art multi-tronic facility will support Gilead’s growing pipeline of drugs and has been jointly designed by both Gilead and PharmaChem, who...